Associate Professor in Medicine-Cardiology, Northwestern University Medical School
Cardiology
Dr. Hossein Ardehali, MD
|
|
Give Review
Doctor Hossein Ardehali, MD is an expert in the field of Cardiology. He attended Vanderbilt University School of Medicine. He received 3 awards: "Elected Member", "Meaningful Use Stage 1 Certification" and "Super Doctor". Hossein Ardehali is a published physician. He has 54 publications published. The most current publication "Insulin-induced hexokinase II expression is reduced in obesity and NIDDM." Doctor Hossein Ardehali, MD accepts all Medicare patients.
Publications
- Reduction in mitochondrial iron alleviates cardiac damage during injury.
- Role of heme in cardiovascular physiology and Disease.
- High Cellular Iron Levels Are Associated with Increased HIV Infection and Replication.
- Molecular and cellular basis of viable dysfunctional myocardium.
- When less is more: novel mechanisms of iron conservation.
- ATP-binding cassette B10 regulates early steps of heme synthesis.
- Heme levels are increased in human failing Hearts.
- Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine.
- Transition metals and mitochondrial metabolism in the Heart.
- Mitochondria as a Therapeutic Target in Heart Failure.
- mTOR Regulates Cellular Iron Homeostasis through Tristetraprolin.
- Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.
- Targeting myocardial substrate metabolism in Heart failure: potential for new therapies.
- microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.
- Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis.
- Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.
- Enhancing the metabolic substrate: PPAR-alpha agonists in Heart failure.
- Regulation and cytoprotective role of hexokinase III.
- Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.
- Mitochondrial dysfunction and oxidative damage to sarcomeric proteins.
- Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats.
- Phosphorylation of contractile proteins in response to alpha- and beta-adrenergic stimulation in neonatal cardiomyocytes.
- Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways.
- The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel.
- Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.
- Comparison of survival among patients with connective tissue Disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated Disease).
- Mitochondrial ATP-binding cassette proteins.
- Signaling mechanisms in ischemic preconditioning: interaction of PKCepsilon and MitoK(ATP) in the inner membrane of mitochondria.
- TOM20 and the Heartbreakers: evidence for the role of mitochondrial transport proteins in cardioprotection.
- Targeting of the mitochondrial membrane proteins to the cell surface for functional studies.
- A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained Cardiomyopathy.
- Cytoprotective channels in mitochondria.
- Cardioprotective role of the mitochondrial ATP-binding cassette protein 1.
- Mitochondrial K(ATP) channels in cell survival and death.
- Diagnostic approach to the patient with Cardiomyopathy: whom to biopsy.
- Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line.
- Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity.
- Role of the mitochondrial ATP-sensitive K+ channels in cardioprotection.
- Endomyocardial biopsy plays a role in diagnosing patients with unexplained Cardiomyopathy.
- Acute thrombosis of a separate major coronary artery during initially successful thrombolytic therapy.
- Control of glucose phosphorylation in L6 myotubes by compartmentalization, hexokinase, and glucose transport.
- Fatal disseminated adenoviral infection in a renal transplant patient.
- Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes.
- Regulation of hexokinase II expression in human skeletal muscle in vivo.
- Functional interaction between the N- and C-terminal halves of human hexokinase II.
- Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
- Regulation of hexokinase II activity and expression in human muscle by moderate exercise.
- Effects of insulin on subcellular localization of hexokinase II in human skeletal muscle in vivo.
- Hexokinase II gene: structure, regulation and promoter organization.
- A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians.
- Functional organization of mammalian hexokinase II. Retention of catalytic and regulatory functions in both the NH2- and COOH-terminal halves.
- Human hexokinase II mRNA and gene structure.
- Isolation, characterization and chromosomal localization of a human pseudogene for hexokinase II.
Schools
Vanderbilt University School Of Medicine
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Johns Hopkins University -
Vanderbilt University School of Medicine
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1184750945 | |
| NPPES Provider LastName | ARDEHALI | |
| NPPES Provider FirstName | HOSSEIN | |
| NPPES Provider ZIPCode | 606115975 | |
| NPPES Provider State | IL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 186.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184750945 |
| Last Name Of The Provider | ARDEHALI |
| First Name Of The Provider | HOSSEIN |
| View All |
Similar Doctors
|
|
Dr. Neal Ruggie, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip R. Liebson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerasim Tikoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sung Sup Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca J. Duke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Han Ho Kim, MD |
|
|
Dr. Arthur G. Jones, MD |
|
|
Dr. Benjamin M. Kaplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Z. Merchant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imran W. Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Afshin Farzaneh-Far, MD
This Doctor is OpenDoctor Recommended.
|